Chemical inhibitors of I1PP2A include a series of compounds that directly target the phosphatase activity of this protein. Okadaic Acid, for instance, is a potent inhibitor that binds to I1PP2A and impedes its ability to dephosphorylate substrates, thereby maintaining the phosphorylation state that is essential for the regulation of various cellular processes. Similarly, Cantharidin exerts its inhibitory effects by binding to the active site of I1PP2A, which blocks the protein's catalytic function. Calyculin A operates in a comparable manner, competing with the natural substrates of the protein, which leads to a reduction in I1PP2A's activity. Endothall also disrupts the dephosphorylation process by inhibiting I1PP2A, effectively altering the phosphorylation dynamics within the cell.
Tautomycin, another inhibitor, selectively interacts with I1PP2A to reduce its phosphatase activity, leading to an accumulation of phosphorylated proteins that would normally be substrates for I1PP2A. Microcystin variants such as Microcystin-LR, Microcystin-RR, and Microcystin-YR bind to I1PP2A and other related phosphatases, resulting in a comprehensive inhibition of their activity. This binding ensures that the proteins that are typically regulated by I1PP2A remain in their phosphorylated state. Moreover, Rubratoxin B targets PP2A and thus indirectly inhibits I1PP2A by similar mechanisms, maintaining high levels of protein phosphorylation. Norcantharidin, a structural analog of Cantharidin, shares this inhibitory action on I1PP2A, offering an alternative compound that hinders the dephosphorylation process. Demethylasterriquinone B1 and Perphenazine, though not classical phosphatase inhibitors, have been found to inhibit I1PP2A activity. Consequently, these chemicals enforce a hyper-phosphorylated state by preventing I1PP2A from performing its role in cellular signaling pathways. Together, these inhibitors provide a diverse set of tools for controlling the activity of I1PP2A and manipulating the phosphorylation status of its downstream targets.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), directly inhibiting I1PP2A's phosphatase activity, leading to a reduction in its ability to dephosphorylate its substrates. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases PP1 and PP2A, directly affecting I1PP2A by preventing it from catalyzing the dephosphorylation of its target proteins. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, specifically inhibits PP1 and PP2A, and thereby inhibits I1PP2A by stabilizing the phosphorylated state of its substrates. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall acts as an inhibitor of PP2A, and thus would inhibit I1PP2A by blocking its phosphatase activity and maintaining the phosphorylation of its targets. | ||||||
Norcantharidin | 29745-04-8 | sc-280719 | 5 g | $113.00 | 2 | |
Norcantharidin is a demethylated analog of cantharidin that inhibits PP1 and PP2A, thereby inhibiting I1PP2A's ability to dephosphorylate its protein substrates. | ||||||
Perphenazine | 58-39-9 | sc-208161 | 100 mg | $190.00 | ||
Perphenazine, an antipsychotic drug, has been found to inhibit PP2A activity, thereby leading to the inhibition of I1PP2A by maintaining the phosphorylation status of its substrates. | ||||||